30
Views
19
CrossRef citations to date
0
Altmetric
Original Article

The Role of Immunophenotype in Acute Lymphoblastic Leukemia of Infant Age

, , &
Pages 51-60 | Received 30 Oct 1993, Published online: 01 Jul 2009

References

  • Hammond D., Sather H., Nesbit N., Miller D., Coccia P., Bleyer A., Lukens J., Siegel S. Analysis of prognostic factors in acute lymphoblastic leukemia. Med. Pediatr. Oncol. 1986; 14: 124–134
  • Reaman G., Zeltzer P., Bleyer W.A., Amendola B., Level C., Sather H., Hammond D. Acute lymphoblastic leukemia in infants less than one year of age: A cumulative experience of the Childrens Cancer Study Group. J. Clin. Oncol. 1985; 3: 1513–1521
  • Crist W., Pullen J., Boyett J., Falletta J., van Eys J., Borowitz M., Jackson J., Dowell B., Frankel L., Quddus F., Ragab A., Vietti T. Clinical and biologic features predict a poor prognosis in acute lymphoid leukemias in infants: A Pediatric Oncology Group study. Blood 1986; 67: 135–140
  • Ludwig W.D., Bartram C.R., Harbott J., Koller U., Haas O.A., Hansen-Hagge T., Heil G., Seibt-Jung H., Teichmann J.V., Ritter J., Knapp W., Gadner H., Thiel E., Riehm H. Phenotypic and genotypic heterogeneity in infant acute leukemia. I. Acute Lymphoblastic Leukemia. Leukemia 1989; 3: 431–439
  • Chuu W.M., Tieng H.F., Lin D.T., Lin K.H., Su I.J., Chen B.W., Lin K.S., Liang D.C. Infant leukemia: An analysis of nine Chinese patients. Am. J. Hematol. 1990; 34: 246–251
  • Bucksy P., Sauter S., Dopfer R., Gerein R., Kuehl J., Reiter A., Ritter J., Riehm H. Acute lymphoblastic leukemia in infants: Clinical characteristics and response to therapy in the multicenter therapy studies ALL-BFM 70/76/79/81/83/86. Cancer in the first year of life, F. Lampert, L. Cordero, A. Pession. Karger Verlag, Basel 1989; 18–29
  • Gibbson B., Katz F.E., Ganly P., Chessells J.M. Infant acute lymphoblastic leukaemia with t(11;19). Br. J. Haematol. 1990; 74: 264–269
  • Dinndorf P.A., Reaman G.H. Acute lymphoblastic leukemia in infants: Evidence for B cell origin of disease by use of monoclonal antibody phenotyping. Blood 1986; 68: 975–978
  • Pui C.-H., Raimondi S.C., Murphy S.B., Ribeiro R.C., Kalwinsky D.K., Dahl G.V., Crist W.M., Williams D.L. An analysis of leukemic cell chromosomal features in infants. Blood 1987; 69: 1289–1293
  • Ishii E., Okamura J., Tsuchida M., Kobayashi Akiyama Y., Nakahata T., Kojima S., Hanada R., Horibe K., Sato T., Komada Y., Kimura K., Sakaguchi C., Hosoya R., Oda M., Tsunematsu Y., Kawa K., Konishi S., Tsuki-Moto I., Matsuyama K., Ueda K. Infant leukemia in Japan: Clinical and biological analysis of 48 cases. Med. Pediatr. Oncol. 1991; 19: 28–32
  • Stark B., Vogel R., Cohen I.J., Umiel T., Mammon Z., Rechavi G., Kaplinsky C., Potzanik D., Dvir A., Yaniv Y., Goshen Katzir N., Ramot B., Zaizov R. Biologic and cytogenetic characteristics of leukemia in infants. Cancer 1989; 63: 117–125
  • Kaneko T., Shikano T., Maseki N., Sakurai M., Takeda T., Hiyoshi Y., Mimaya J.-I., Fujimoto T. Clinical characteristics of infant acute leukemia with or without 1 1q23 translocation. Leukemia 1988; 2: 672–676
  • Katz F., Malcolm S., Gibbons B., Tilly R., Lam G., Robertson M.E., Czepulkowski B., Chessells J. Cellular and molecular studies on infant null acute lymphoblastic leukemia. Blood 1988; 71: 1438–1447
  • Haupt R., Comelli A., Garre M.L., Deferrari R., Fugazza G., Basso G., Rosanda C., Sessarego M., Sansone R. Cytogenetics of infantile leukemias and its correlations with bio-clinical features. The “G. Gaslini” children's hospital experience over a 9-years period. Haematologica 1991; 76: 109–112
  • Mastrangelo R., Poplack D., Bleyer A., Riccardi R., Sather H., D'Angio G. Report and recommendations of the Rome workshop concerning poor-prognosis acute lymphoblastic leukemia in children: biologic bases for staging, stratification, and treatment. Med. Pediatr. Oncol. 1986; 14: 191–194
  • Guazzelli C., Rosi A., Pession A., Rondelli R., Lippi A., Giuliano M., Paolucci P. Acute lymphoblastic and non-lymphoblastic leukemia in infants less than one year of age: A cumulative experience of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP). Cancer in the first year of life, F. Lampert, A. Cordero, A. Pession. Karger Verlag, Basel 1990; 10–17
  • Paolucci G., Masera G., Vacchi V., Marsoni S., Pession A., Zurlo M.G. Treating childhood acute lymphoblastic leukaemia (ALL): Summary of ten years' experience in Italy. Med. Pediatr. Oncol. 1989; 17: 83–91
  • Riehm H., Feickert H.J., Lampert F. Acute lymphoblastistic leukemia. Cancer in Children, 2nded., P.A. Voute, A. Barret, H. J. G. Bloom, J. Lemerle, M.K. Neidhart. Springer-Verlag, Berlin 1986; 101–108
  • Negri D., Haupt R., Comelli A., Boni L., Stringini P., Sansone R. An analysis of infantile acute leukemia by a case-control study. Rivista Italiana Pediatr. 1991; 17: 178–184
  • Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D. A. G., Gralnick H.R., Sultan C. Proposal for the classification of the acute leukemias (French-British-American FAB Cooperative Group). Br. J. Haematol. 1976; 33: 451–458
  • Basso G., Putti M.C., Cantu-Rajnoldi A., Saitta M., San-Tostasi T., Santoro N., Lippi A., Comelli A., Felici L., Favre C., Russo Mancuso G., Guglielmi C., Paolucci A., Biondi A., Rondelli R., Pession A. The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicenter study (AIEOP). Br. J. Haematol. 1992; 81: 184–191
  • Nadler L.M., Korsmeyer S.J., Anderson K.C., Boyd A.W., Slaugenhoupt B., Park E., Jensen J., Coral F., Mayer R.J., Sallan S.E., Ritz I., Schlossman S.F. B cell origin of non-T cell acute lymphoblastic leukemia. A model for discrete stages of neoplastic and normal pre-B differentiation. J. Clin. Invest. 1984; 74: 332–340
  • Van der Does-van den Berg A., Bartram C.R., Basso G., Benoit C.M., Biondi A., Debatin K.M., Haas O.A., Harbott J., Kamps W.A., Koller U., Lampert F., Ludwig W.D., Niemeyer C.M., Van Wering E.R. Minimal requirements for the diagnosis, classification and evaluation of the treatment of childhood acute lymphoblastic leukemia (ALL) in the “BFM Family” Cooperative Group. Med. Pediatr. Oncol. 1992; 20: 497–505
  • Basso G., Rondelli R., Putti M.C., Granchi D., Cocito M.G., Saitta M., Santostasi T., Guglielmi C., Lippi A., Santoro N., Russo M.G., Pession A., Arico' M., Biondi A. Incidence and prognostic significance of immunophenotypic subgroups in childhood acute lymphoblastic leukemia: the experience of the AIEOP cooperative study. Recent Results in Cancer Research, W.-D. Ludwig, E. Thiel. Springer Verlag, Berlin 1993; 297–307
  • Biondi A., Rossi V., Franca di Celle P., Carbone A., Benvestito S., Busca A., Giudici G., Giachino C., Basso G., Foa R., Migone N. Unique genotypic features of infant acute lymphoblastic leukaemia at presentation and at relapse. Br. J. Haematol. 1992; 80: 472–479
  • Crist W.M., Carroll A.J., Pui C.H. Pre-B-cell acute lymphoblastic leukemia in childhood. Leukemia and Lymphoma 1990; 3: 1–6
  • Crist W.M., Carrol A.J., Shuster J.J., Behm F.G., Whitehead M., Vietti T.J., Look A.T., Mahoney D., Ragab A., Pullen D.J., Land V.J. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): A Pediatric Oncology Group study. Blood 1990; 76: 117–122
  • Raimondi S.C., Behm F.G., Roberson P.K., Williams D.L., Pui C.-H., Crist W.M., Look A.T., Rivera G.K. Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19). J. Clin. Oncol. 1990; 8: 1380–1388
  • Seeker-Walker L.M., Berger R., Fenaux P., Lai J.L., Nelken B., Garson M., Michael P.M., Hagemeijer A., Harrison C.J., Kaneko Y., Rubin C.M. Prognostic significance of the balanced t(1;19) and unbalanced der(19)t(1;19) translocations in acute lymphoblastic leukemia. Leukemia 1992; 6: 363–369
  • Bollum F.J. Terminal deoxynucleotidyl transferase as a haematopoietic cell marker. Blood 1985; 54: 1203–1215
  • Bradstock K.F., Kerr A., Kabrol A., Favaloro E.J., Hewson J.W. Coexpression of pi65 myeloid surface antigen and terminal deoxynucleotidyl transferase: A comparison of acute myeloid leukemia and bone marrow cells. Am. J. Hematol. 1986; 23: 43–50
  • Foa' R., Casorati G., Giubellino M.C., Basso G., Schiro' R., Pizzolo G., Lauria F., Lefrance M.P., Rabbits T.H., Migone N. Rearrangements of immunoglobulin and T cell receptor beta and gamma genes are associated with terminal deoxynucleotidyl transferase expression in acute myeloid leukemia. J. Exp. Med. 1987; 165: 879–890
  • Greaves M.F., Chan L.C., Furley A. J. W., Watt S.M., Molgaard H.V. Lineage promiscuity in hae-mopoietic differentiation and leukemia. Blood 1986; 67: 1–11
  • Mirro J., Zipf T.F., Pui C.-H., Kitchingman G., Williams D., Melvin S., Murphy S.B., Stass S. Acute mixed lineage leukemia: Clinicopathologic correlations and prognostic significance. Blood 1985; 66: 1115–1123
  • Bradstock K.F., Kirk J., Grimsley P.G., Kabral A., Hughes W.G. Unusual immunophenotypes in acute leukemias: incidence and clinical correlations. Br. J. Haematol. 1989; 72: 512–518
  • Cross A.H., Goorha R.M., Nuss R., Behm F.G., Murphy S.B., Kalwinsky D.K., Raimondi S., Kitchingman G.R., Mirro J. Acute myeloid leukemia with T-lymphoid features: A distinct biological and clinical entity. Blood 1988; 2: 579–587
  • Zutter M.M., Martin P.J., Hanke D., Kidd P.G. CD7+ acute non-lymphocytic leukemia: Evidence for an early multipotential progenitor. Leuk. Res. 1990; 14: 23–26
  • Ludwig W.-D., Bartram C.R., Ritter J., Raghavachar A., Hiddemann W., Heil G., Harbott J., Seibt-Jung H., Teichman J.V., Riehm H. Ambiguous phenotypes and genotypes in 16 children with acute leukemia as characterized by multiparameter analysis. Blood 1988; 71: 1518–1528
  • Lenkei R., Biork O., Ost A., Biberfeld P. Expression of CD 15 as predictor of relapse in children with acute lymphoblastic leukemia of the pre-B type. Leuk. Res. 1991; 15(4)189–194
  • Sobol R.E., Mick R., Royston I., Davey F.R., Ellison R.R., Newman R., Cuttner J., Griffin J.D., Colins H., Nelson D.A., Bloomfield C.D. Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. A'. Engl. J. Med. 1987; 316: 1111–1117
  • Childs C.C., Hirsch-Ginsberg C., Walters R.S., Anders-Son B.S., Reuben J., Trujillo J.M., Cork A., Stass S.A., Freireich E.J., Zipf T.F. Myeloid surface antigen-positive acute lymphoblastic leukemia (MYA + ALL): Immunophenotypic, ultrastructural, cytogenetic and molecular characteristics. Leukemia 1989; 11: 777–783
  • Guyotat D., Campos L., Shi Z.H., Charrin C., Treille D., Magaud J.P., Fiere D. Myeloid surface antigen expression in adult acute lymphoblastic leukemia. Leukemia 1990; 9: 664–666
  • Cantu-Rajnoldi A., Putti M.C., Saitta M., Granchi D., Foa R., Schiliro R., Castagni M., Valeggio C., Jankovic M., Miniero R., Paolucci P., Basso G. Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: Relationship with the stage of differentiation and clinical significance. Br. J. Haematol. 1991; 79: 40–44
  • Matutes E., Pombo de Oliveira M., Foroni L., Morilla R., Catovsky D. The role of ultrastructural cytochemistry and monoclonal antibodies in clarifying the nature of undifferentiated cells in acute leukemia. Br. J. Haematol. 1988; 69: 205–211
  • Mirro J., Kitchingman G., Williams D., Lauzon G.J., Lin C.C., Callihan T., Zipf T.F. Clinical and laboratory characteristics of acute leukemia with the t(4;11) translocation. Blood 1986; 67: 689–697
  • Umiel T., Nadler L.M., Cohen I.J., Levine H., Stark B., Mammon Z., Dzaldetti M., Rechavi G., Simoni F., Katzir N., Ramot B., Zaizov R. Undifferentiated leukemia of infancy with t(11;17) chromosomal rearrangement. Cancer 1987; 59: 1143–1149
  • Schardt C., Ottman O.G., Hoelzer D., Ganser A. Acute lymphoblastic leukemia with the (4;11) translocation: Combined cytogenetic, immunological and molecular genetic analyses. Leukemia 1992; 6: 370–374
  • Stong R.C., Korsmeyer S.J., Parkin J.L., Arthur D.C., Kersey J.H. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood 1985; 65(1)21–31
  • Shkolnik T., Schlossman S.F., Griffin J.D. Acute undifferentiated leukemia: Induction of partial differentiation by phorbolester. Leuk. Res. 1985; 9: 11–17
  • Basso G., Putti M.C., Catoretti G., Consolini R., Galdiolo D., Gugliehni C., Milanesi C., Testi A.M., Zillo Monte Xillo M., Zulian F., Foa' R. Heterogeneity of TdT+, HLA-DR+ acute leukemia: Immunological, immunocytochemical and clinical evidence of lymphoid and myeloid origin. Eur. J. Haematol. 1987; 38: 111–116
  • Heil G., Gunsilius E., Raghavachar A., Bartram C.R., Ganser A., Kurrle E., Aydemir U., Loffler H., Hoelezer D., Thiel E., Heimpel H. Ultrastructural demonstration of peroxidase expression in acute unclassified leukemias: Correlation to immunophenotype'and treatment outcome. Blood 1991; 77(6)1305–1312
  • Zaki S.R., Austin G.E., Swan D., Srinivasan A., Ragab A.H., Chan W.C. Human myeloperoxidase gene expression in acute leukemia. Blood 1989; 74: 2096–2102
  • Eguiguren J.M., Schell M.J., Crist W.M., Kunkel K., Rivera G. Complications and outcome in childhood acute lymphoblastic leukemia with hyperleukocytosis. Blood 1992; 79: 871–875
  • Pui C.-H., Behm F.G., Songh B., Rivera G.K., Schell M.J., Roberts W.M., Crist W.M., Mirro J. Myeloid associated antigen expression lacks prognostic value in childhood acute lymphoblastic leukemia treated with intensive multiagent chemotherapy. Blood 1990; 75: 198–202
  • Urbano-Ispizua A., Matutes E., Villamor N., Ribera J.M., Feliu E., Monserrat E., Granena A., Vives-Corrons J.-L., Rozman C. Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukemia. Br. J. Haematol. 1990; 75: 202–207
  • Wiersma S.R., Ortega J., Sobel E., Weinberg K.I. Clinical importance of myeloid-antigen expression in acute lymphoblastic leukemia of childhood. N. Engl. J. Med. 1991; 324: 800–808
  • Borowitz M.J., Sinister J.J., Land V.J., Steuber C.P., Pullen D.J., Vietti T.J. Myeloid-antigen expression in childhood acute lymphoblastic leukemia. N. Engl. J. Med. 1991; 325: 1379–1380
  • Pui C.H., Head S.C., Raimondi D.R., Schell M.J., Rivera G.K., Mirro J., Crist W.M., Behm F.G. Characterization of childhood acute leukemia with multiple myeloid and lymphoid markers at diagnosis and at relapse. Blood 1991; 78: 1327–1337
  • Pui C.H., Frankel L.S., Carroll A.J., Raimondi S.C., Shuster J.J., Head D.R., Crist W.M., Land V.J., Pullen J.D., Steuber C.P., Behm F.G., Borowitz M.J. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23): A collaborative study of 40 cases. Blood 1991; 77(3)440–447
  • Pui C.-H. Acute leukemias with the t(4;11)(q21;q23). Leukemia and Lymphoma 1992; 7: 173–179
  • Hayashi Y., Kobayashi Y., Hirai H., Hanada R., Yamamoto K., Abe T., Sugita K., Nakazawa S., Suetake N., Hoshino H., Kuroume T., Bessho F., Hayakawa H., Takaku F. Immunoglobulin heavy chain rearrangements and mixed lineage characteristics in acute leukemia with 11q23 translocations. Blood 1988; 67: 484–491
  • Cimino G., Lo Coco F., Biondi A., Elia L., Luciano A., Croce C.M., Masera G., Mandelli F., Canaani E. ALL-1 gene at chromosome 11q23 is consistently altered in acute lymphoblastic leukemia of early infancy. Blood 1993; 82: 544–546
  • Chen C.S., Sorensen P. H. B., Dome P.H., Reaman G.H., Korsmeyer S.J., Heerema N.A., Hammond G.D., Kersey J. Molecular rearrangements on chromosome 11q23, predominate in infant acute lymphoblastic leukemia and are associated with specific biologic variables and poor outcome. Blood 1993; 81: 2386–2393
  • Cimino G., Moir D.T., Canaani O., Williams K., Crist W.M., Katzav S., Cannizaro L., Nowell P.C., Croce C.M., Canaani E. Cloning of ALL-1, the locus involved in leukemias with the t(4;11)(q21;q23), t(9;11)(p22;q23) and t(11;19)(q23;p13) chromosome translocations. Cancer Res. 1991; 51: 6712–6714
  • Pedersen-Bjegaard J. Acute lymphoid leukemia with t(4;11)(q21;q23) following chemotherapy with cytostatic agents targeting at DNA topoisomerase II. Leuk. Res. 1992; 16: 733–735
  • Pui C.-H., Behm F.G., Crist W.M. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343–362

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.